Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
91 hedge funds and large institutions have $556M invested in Epizyme, Inc in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 50 increasing their positions, 11 reducing their positions, and 13 closing their positions.
355% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 11
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
15% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 13
2% more funds holding
Funds holding: 89 → 91 (+2)
2% more capital invested
Capital invested by funds: $543M → $556M (+$12.6M)
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$17M |
| 2 |
Primecap Management
Pasadena,
California
|
+$12.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$12.1M |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$11.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.25M |
| 2 |
FAM
Fred Alger Management
New York
|
-$965K |
| 3 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
-$801K |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$564K |
| 5 |
PCM
Piermont Capital Management
St. Louis,
Missouri
|
-$516K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
101
Panagora Asset Management
Boston,
Massachusetts
| – | -$57K | -3,573 | Closed |
|
102
Simplex Trading
Chicago,
Illinois
| – | -$4.99K | -493 | Closed |
|
|
WTB
103
Washington Trust Bank
Spokane,
Washington
| – | -$3K | -200 | Closed |
|
EPZM Hedge Fund Activity: Q1 2016 in Review
91 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q1 2016, worth a combined $556M — up 2.3% from $543M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new EPZM positions and 13 closed out — a net gain of 2 holders — while 50 added to existing stakes and 11 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $17M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $1.25M sold.
- 91 institutional investors held Epizyme, Inc (EPZM) as of Q1 2016, up from 89 in Q4 2015.
- Funds reported $556M of Epizyme, Inc stock for Q1 2016, up 2.3% quarter-over-quarter.
- 15 funds opened new Epizyme, Inc positions in Q1 2016 and 13 closed out, a net change of +2 holders.
- The largest Epizyme, Inc buyer in Q1 2016 was Fidelity Investments, an estimated $17M added.
- The largest Epizyme, Inc seller in Q1 2016 was Lord, Abbett & Co, an estimated $1.25M sold.
Based on aggregated 13F filings for Q1 2016.